Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare disorder associated with high morbidity and mortality despite currently available treatments. We compared the phosphoproteome of lung tissue from subjects with idiopathic PAH (iPAH) obtained at the time of lung transplant with control lung tissue. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Ravikumar Sitapara, TuKiet T. Lam, Aneta Gandjeva, Rubin M. Tuder, Lawrence S. Zisman
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Pulmonary Circulation
Subjects:
Online Access:https://doi.org/10.1177/20458940211031109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850147601776640000
author Ravikumar Sitapara
TuKiet T. Lam
Aneta Gandjeva
Rubin M. Tuder
Lawrence S. Zisman
author_facet Ravikumar Sitapara
TuKiet T. Lam
Aneta Gandjeva
Rubin M. Tuder
Lawrence S. Zisman
author_sort Ravikumar Sitapara
collection DOAJ
description Pulmonary arterial hypertension (PAH) is a rare disorder associated with high morbidity and mortality despite currently available treatments. We compared the phosphoproteome of lung tissue from subjects with idiopathic PAH (iPAH) obtained at the time of lung transplant with control lung tissue. The mass spectrometry‐based analysis found 60,428 phosphopeptide features from which 6622 proteins were identified. Within the subset of identified proteins there were 1234 phosphopeptides with q < 0.05, many of which are involved in immune regulation, angiogenesis, and cell proliferation. Most notably there was a marked relative increase in phosphorylated (S378) IKZF3 (Aiolos), a zinc finger transcription factor that plays a key role in lymphocyte regulation. In vitro phosphorylation assays indicated that GSK3 alpha and/or GSK3 beta could phosphorylate IKZF3 at S378. Western blot analysis demonstrated increased pIKZF3 in iPAH lungs compared to controls. Immunohistochemistry demonstrated phosphorylated IKZF3 in lymphocytes surrounding severely hypertrophied pulmonary arterioles. In situ hybrization showed gene expression in lymphocyte aggregates in PAH samples. A BCL2 reporter assay showed that IKZF3 increased BCL2 promoter activity and demonstrated the potential role of phosphorylation of IKZF3 in the regulation of BCL mediated transcription. Kinase network analysis demonstrated potentially important regulatory roles of casein kinase 2, cyclin‐dependent kinase 1 (CDK1), mitogen‐associated protein kinases (MAPKs), and protein kinases (PRKs) in iPAH. Bioinformatic analysis demonstrated enrichment of RhoGTPase signaling and the potential importance of cGMP‐dependent protein kinase 1 (PRKG). In conclusion, this unbiased phosphoproteomic analysis demonstrated several novel targets regulated by kinase networks in iPAH, and reinforced the potential role of immune regulation in the pathogenesis of iPAH. The identified up‐ and down‐regulated phosphoproteins have potential to serve as biomarkers for PAH and to provide new insights for therapeutic strategies.
format Article
id doaj-art-b10c7c1b697a47e4b1626811a4f66ea0
institution OA Journals
issn 2045-8940
language English
publishDate 2021-07-01
publisher Wiley
record_format Article
series Pulmonary Circulation
spelling doaj-art-b10c7c1b697a47e4b1626811a4f66ea02025-08-20T02:27:31ZengWileyPulmonary Circulation2045-89402021-07-0111311510.1177/20458940211031109Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertensionRavikumar Sitapara0TuKiet T. Lam1Aneta Gandjeva2Rubin M. Tuder3Lawrence S. Zisman4Rensselaer Center for Translational Research Inc.TroyNYUSADepartment of Molecular Biophysics and BiochemistryYale UniversityYale UniversityNew HavenCTUSAProgram in Translational Lung ResearchDivision of Pulmonary Sciences and Critical Care MedicineUniversity of Colorado School of MedicineAuroraCOUSAProgram in Translational Lung ResearchDivision of Pulmonary Sciences and Critical Care MedicineUniversity of Colorado School of MedicineAuroraCOUSARensselaer Center for Translational Research Inc.TroyNYUSAPulmonary arterial hypertension (PAH) is a rare disorder associated with high morbidity and mortality despite currently available treatments. We compared the phosphoproteome of lung tissue from subjects with idiopathic PAH (iPAH) obtained at the time of lung transplant with control lung tissue. The mass spectrometry‐based analysis found 60,428 phosphopeptide features from which 6622 proteins were identified. Within the subset of identified proteins there were 1234 phosphopeptides with q < 0.05, many of which are involved in immune regulation, angiogenesis, and cell proliferation. Most notably there was a marked relative increase in phosphorylated (S378) IKZF3 (Aiolos), a zinc finger transcription factor that plays a key role in lymphocyte regulation. In vitro phosphorylation assays indicated that GSK3 alpha and/or GSK3 beta could phosphorylate IKZF3 at S378. Western blot analysis demonstrated increased pIKZF3 in iPAH lungs compared to controls. Immunohistochemistry demonstrated phosphorylated IKZF3 in lymphocytes surrounding severely hypertrophied pulmonary arterioles. In situ hybrization showed gene expression in lymphocyte aggregates in PAH samples. A BCL2 reporter assay showed that IKZF3 increased BCL2 promoter activity and demonstrated the potential role of phosphorylation of IKZF3 in the regulation of BCL mediated transcription. Kinase network analysis demonstrated potentially important regulatory roles of casein kinase 2, cyclin‐dependent kinase 1 (CDK1), mitogen‐associated protein kinases (MAPKs), and protein kinases (PRKs) in iPAH. Bioinformatic analysis demonstrated enrichment of RhoGTPase signaling and the potential importance of cGMP‐dependent protein kinase 1 (PRKG). In conclusion, this unbiased phosphoproteomic analysis demonstrated several novel targets regulated by kinase networks in iPAH, and reinforced the potential role of immune regulation in the pathogenesis of iPAH. The identified up‐ and down‐regulated phosphoproteins have potential to serve as biomarkers for PAH and to provide new insights for therapeutic strategies.https://doi.org/10.1177/20458940211031109pulmonary hypertensionproteomicscell proliferation/cell cycleangiogenesisinflammation
spellingShingle Ravikumar Sitapara
TuKiet T. Lam
Aneta Gandjeva
Rubin M. Tuder
Lawrence S. Zisman
Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
Pulmonary Circulation
pulmonary hypertension
proteomics
cell proliferation/cell cycle
angiogenesis
inflammation
title Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
title_full Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
title_fullStr Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
title_full_unstemmed Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
title_short Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
title_sort phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
topic pulmonary hypertension
proteomics
cell proliferation/cell cycle
angiogenesis
inflammation
url https://doi.org/10.1177/20458940211031109
work_keys_str_mv AT ravikumarsitapara phosphoproteomicanalysisoflungtissuefrompatientswithpulmonaryarterialhypertension
AT tukiettlam phosphoproteomicanalysisoflungtissuefrompatientswithpulmonaryarterialhypertension
AT anetagandjeva phosphoproteomicanalysisoflungtissuefrompatientswithpulmonaryarterialhypertension
AT rubinmtuder phosphoproteomicanalysisoflungtissuefrompatientswithpulmonaryarterialhypertension
AT lawrenceszisman phosphoproteomicanalysisoflungtissuefrompatientswithpulmonaryarterialhypertension